Open access
Open access
Powered by Google Translator Translator

Chest Medicine

Report: Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19

28 Apr, 2020 | 04:45h | UTC

Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands – Radiology

 


IDSA Guidelines on Infection Prevention in Patients with Suspected or Known COVID-19

28 Apr, 2020 | 04:47h | UTC

Infectious Diseases Society of America Guidelines on Infection Prevention in Patients with Suspected or Known COVID-19

See also: Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 Infection

 


Aerodynamic Analysis of SARS-CoV-2 in Two Wuhan Hospitals

28 Apr, 2020 | 04:36h | UTC

Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals – Nature

Commentary: SARS-CoV-2 Found in Aerosols in Hospital Staff Areas, Public Places – NEJM Journal Watch AND Coronavirus Lingers in Air of Crowded Spaces, New Study Finds – Bloomberg AND Expert reaction to a Nature paper presenting evidence for the presence of SARS-CoV-2 RNA in the air – Science Media Centre

 


Study: COVID-19 and Risks Posed to Personnel During Endotracheal Intubation

28 Apr, 2020 | 04:40h | UTC

Exposure to a Surrogate Measure of Contamination From Simulated Patients by Emergency Department Personnel Wearing Personal Protective Equipment – JAMA

Editorial: COVID-19 and Risks Posed to Personnel During Endotracheal Intubation – JAMA

 


Twitter-based Learning for Continuing Medical Education? A New Perspective for a Paradigm Shift in Medical Education, Accelerated by COVID-19

28 Apr, 2020 | 04:28h | UTC

Twitter-based learning for continuing medical education? A new perspective for a paradigm shift in medical education, accelerated by COVID-19 – European Heart Journal

Related: How Twitter is Changing Medical Research (texts on the subject)

 


Richard Lehman’s Covid-19 Reviews—27 April 2020

28 Apr, 2020 | 04:21h | UTC

Richard Lehman’s covid-19 reviews, 27 April 2020 – The BMJ Opinion

In this weekly round-up, Richard Lehman looks at a personal selection of articles of relevance to clinicians dealing with covid-19”

 


Closely Watched Arthritis Drug Disappoints as a Covid-19 Treatment, Studies Show

28 Apr, 2020 | 04:18h | UTC

Closely watched arthritis drug disappoints as a Covid-19 treatment, studies show – STAT

 


Clinical Practice: Mild or Moderate Covid-19

26 Apr, 2020 | 21:35h | UTC

Mild or Moderate Covid-19 – New England Journal of Medicine

 


Management of COVID-19 Respiratory Distress

26 Apr, 2020 | 21:36h | UTC

Management of COVID-19 Respiratory Distress – JAMA

Related Podcast: Coronavirus (COVID-19) Update: Ventilatory Management for COVID-Related Respiratory Failure – JAMA

 

Related Commentary on Twitter

 


Study: The QT Interval in Patients with COVID-19 Treated with Hydroxychloroquine and Azithromycin

26 Apr, 2020 | 21:18h | UTC

The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin – Nature Medicine

Commentary: Expert reaction to paper looking at cardiac abnormalities in patients with COVID-19 treated with hydroxychloroquine and azithromycin – Science Media Centre

 


FDA Safety Alert: Risk of Heart Rhythm Problems with the use of Hydroxychloroquine or Chloroquine for COVID-19

26 Apr, 2020 | 21:20h | UTC

FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems – U.S. Food & Drug Administration

News Release: FDA warning for Hydroxychloroquine or Chloroquine for COVID-19: Risk of Heart Rhythm Problems – Outbreak News Today

 


Respiratory Support in Novel Coronavirus Disease (COVID-19) Patients, with a Focus on Resource-Limited Settings

24 Apr, 2020 | 03:48h | UTC

Respiratory Support in Novel Coronavirus Disease (COVID-19) Patients, with a Focus on Resource-Limited Settings – The American Society of Tropical Medicine and Hygiene

 


Observational Study: Renin-Angiotensin System Inhibitors are Not Associated with Severity or Mortality in Hospitalized Patients with Coronavirus Disease

24 Apr, 2020 | 03:46h | UTC

Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China – JAMA Cardiology

Commentary: Drugs for high blood pressure don’t appear to make COVID-19 worse – Science News

Related Study: Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19 – Circulation Research

 


Perspective: Against Pandemic Research Exceptionalism

24 Apr, 2020 | 03:39h | UTC

Against pandemic research exceptionalism – Science

“Crises are no excuse for lowering scientific standards.”

 


Debate: Is it Wrong to Prioritize Younger Patients with Covid-19?

24 Apr, 2020 | 03:30h | UTC

Is it wrong to prioritise younger patients with covid-19? – The BMJ

Commentary: Should age be a prioritizing factor in deciding who gets treated for COVID-19? – News Medical

 


Perspective: In Defense of Evidence-Based Medicine for the Treatment of COVID-19 ARDS

24 Apr, 2020 | 03:36h | UTC

In Defense of Evidence-Based Medicine for the Treatment of COVID-19 ARDS – Annals of the American Thoracic Society

 


New Data on Remdesivir: No benefit for Patients with Covid-19

24 Apr, 2020 | 03:31h | UTC

New data on Gilead’s remdesivir, released by accident, show no benefit for coronavirus patients. Company still sees reason for hope – STAT

Related: Remdesivir in covid-19 – The BMJ AND What’s Happening With Remdesivir? – Science Translational Medicine AND Slow down your giddyup on Gilead news – Health News Review

 


Hydroxychloroquine and Coronavirus: A Guide to the Scientific Studies so Far

24 Apr, 2020 | 03:28h | UTC

Hydroxychloroquine and coronavirus: a guide to the scientific studies so far – The Guardian

 


Community-acquired Pneumonia: Strategies for Triage and Treatment

24 Apr, 2020 | 03:20h | UTC

Community-acquired pneumonia: Strategies for triage and treatment – Cleveland Clinic Journal of Medicine

 


Clinical Features and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

23 Apr, 2020 | 09:43h | UTC

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area – JAMA

Commentary: Almost Every Hospitalized Coronavirus Patient Has Another Underlying Health Issue, According to a Study of New York Patients – TIME

 


Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection

23 Apr, 2020 | 09:41h | UTC

Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection – JAMA

Related: Study Validates Loss of Smell and Taste as Symptoms of Covid-19

 


[Preprint] Study: Saliva is More Sensitive for SARS-CoV-2 Detection in COVID-19 Patients than Nasopharyngeal Swabs

23 Apr, 2020 | 09:36h | UTC

Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs – medRxiv

 


Opinion: A Call for Rational Intensive Care in the Era of COVID-19

23 Apr, 2020 | 09:34h | UTC

A Call for Rational Intensive Care in the Era of COVID-19 – American Journal of Respiratory Cell and Molecular Biology

 


Editorial: Remdesivir in Covid-19

23 Apr, 2020 | 09:35h | UTC

Remdesivir in covid-19 – The BMJ

Related: What’s Happening With Remdesivir? – Science Translational Medicine AND Slow down your giddyup on Gilead news – Health News Review

 


Low-cost, Easy-to-build Non-Invasive Pressure Support Ventilator for Under-resourced Regions: Open Source Hardware Description, Performance and Feasibility Testing

23 Apr, 2020 | 09:26h | UTC

Low-cost, easy-to-build non-invasive pressure support ventilator for under-resourced regions: open source hardware description, performance and feasibility testing – European Respiratory Journal

Commentary: Low-cost, easy-to-build ventilator performs similarly to high-quality commercial device – European Lung Foundation

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.